Sana Biotechnology Inc.

$SANA is up big today after the company presented Phase 1 trial results for its CAR T-cell therapy at the JPMorgan Healthcare Conference

Share this article:

About the Author:

Sana Biotechnology Inc.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup